Capstone Holding updates CEO 356,250-share grant
Lipman Matthew E. reported acquisition or exercise transactions in this Form 4 filing.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4/A
Rhea-AI Filing Summary
Lipman Matthew E. reported acquisition or exercise transactions in this Form 4 filing.
Capstone Holding Corp. amended a prior insider report to clarify that Chief Executive Officer Matthew E. Lipman received a grant of 356,250 shares of common stock as restricted stock awards on March 30, 2026, vesting in full on March 30, 2029, for no consideration.
After this grant, he directly holds 2,920,340 shares of common stock. This figure excludes an additional 121,774 shares he controls through BP Peptides, LLC.
Insider Trade Summary
Grant/Award: 356,250 shares
Grant/Award
1 txn
Insider
Lipman Matthew E.
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1, F2, F3 | 356,250 | -- | -- |
Holdings After Transaction:
Common Stock — 2,920,340 shares (Direct)
Holdings Before and After:
Common Stock, 2,564,090 to 2,920,340 shares (Direct)
Footnotes (3)
- F1. This Form 4/A is being filed solely to correct the nature of the shares reported as granted on April 1, 2026. This amendment reflects that the shares granted were shares of common stock, rather than restricted stock units.
- F2. Including 356,250 shares of common stock granted to the Reporting Person on March 30, 2026 as restricted stock awards, for no consideration. The restricted stock awards vest in full on March 30, 2029, which is the third anniversary of the March 30, 2026 grant date, subject to the Reporting Person's continued service through such vesting date.
- F3. Excludes 121,774 shares controlled by the Reporting Person, through his control of BP Peptides, LLC.
Key Figures
Restricted stock awards granted: 356,250 shares of common stock
Vesting date: March 30, 2029
Direct holdings after grant: 2,920,340 shares
+1 more
4 metrics
Restricted stock awards granted
356,250 shares of common stock
Shares granted to CEO Matthew E. Lipman on March 30, 2026 as restricted stock awards
Vesting date
March 30, 2029
Restricted stock awards vest in full on the third anniversary of the grant date
Direct holdings after grant
2,920,340 shares
Total shares of Capstone common stock directly owned by the CEO following the award
Indirectly controlled shares excluded
121,774 shares
Shares controlled through BP Peptides, LLC that are excluded from the direct holdings total
Key Terms
restricted stock awards, restricted stock units, Form 4/A, continued service
4 terms
restricted stock awards financial
"Including 356,250 shares of common stock granted to the Reporting Person on March 30, 2026 as restricted stock awards"
Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.
restricted stock units financial
"reflects that the shares granted were shares of common stock, rather than restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Form 4/A financial
"This Form 4/A is being filed solely to correct the nature of the shares reported"
Form 4/A is an amended filing that corrects or updates an earlier Form 4, the mandatory report that insiders (like company executives, directors, or large shareholders) must file when their ownership stakes change. Think of it as an edited receipt showing who bought or sold stock and when; investors use it to track insider confidence, detect potential conflicts, and spot trading patterns that might signal future company prospects.
continued service financial
"vest in full on March 30, 2029, which is the third anniversary ... subject to the Reporting Person's continued service"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What change does Capstone Holding Corp. (CAPS) report in this Form 4/A?
The amendment clarifies that a previously reported equity grant to CEO Matthew E. Lipman consisted of common stock, not restricted stock units. It restates the nature of the March 30, 2026 award without changing the reported share count or vesting schedule.
When do the CAPS CEO’s restricted stock awards vest?
The 356,250 restricted stock awards granted on March 30, 2026 vest in full on March 30, 2029. Vesting is conditioned on Matthew E. Lipman’s continued service with Capstone Holding Corp. through that vesting date, as described in the grant terms.
What indirect holdings are noted for the CAPS CEO in this amendment?
The amendment notes that the CEO controls 121,774 additional shares through BP Peptides, LLC. These indirectly controlled shares are specifically excluded from the reported post-transaction direct holding total of 2,920,340 shares of common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
